dc.contributor.author | Conseil exécutif, 144 | en_US |
dc.coverage.spatial | Genève | en_US |
dc.date.accessioned | 2019-09-17T07:46:08Z | |
dc.date.available | 2019-09-17T07:46:08Z | |
dc.date.issued | 2018 | |
dc.identifier.govdoc | EB144/17 | |
dc.identifier.uri | https://iris.who.int/handle/10665/327423 | |
dc.description | 34 p. | en_US |
dc.language.iso | fr | en_US |
dc.publisher | Organisation mondiale de la Santé | en_US |
dc.subject.mesh | Vaccines | en_US |
dc.subject.mesh | Drugs, Essential | en_US |
dc.subject.mesh | Health Services Accessibility | en_US |
dc.title | Médicaments, vaccins et produits sanitaires : accès aux médicaments et aux vaccins : rapport du Directeur général | en_US |
dc.type | Governing body documents | en_US |
who.relation.languageVersion | 10665/327421 | en_US |
who.relation.languageVersion | 10665/327422 | en_US |
who.relation.languageVersion | 10665/327424 | en_US |
who.relation.languageVersion | 10665/327425 | en_US |
who.relation.languageVersion | 10665/327426 | en_US |